The combination produces 15-25% body weight loss - significantly superior to semaglutide's 10-15% alone - by targeting both GLP-1 and amylin receptors simultaneously
Individuals interested in its use should consult a qualified healthcare professional before use
CJC-1295 no DAC: 0.1mg Ipamorelin: 0.15mg BPC-157: 0.25mg GHK-Cu: 1mg CJC-1295 no DAC: 0.1mg Ipamorelin: 0.15mg BPC-157: 0.25mg (optional second dose) TB-500: 2.5mg during loading, 2mg maintenance Tirzepatide: Per prescribed escalation schedule This protocol requires significant commitment to injection frequency but addresses all major concerns simultaneously
Skin Rejuvenation & Anti-Aging (Collagen & Elastin Boosting) Dosage: 25 mg per day (subcutaneous injection) or 0.1%2% topical cream Cycle: Continuous use for 812 weeks, with a 4-week break Administration: Injectable: Best taken before bed for cellular repair Topical: Apply twice daily for skin improvement Stacking: With Epitalon for telomere extension and longevity With Thymosin Beta-4 (TB-500) for wound healing synergy With MOTS-c for mitochondrial skin regeneration Expected Benefits: Increased collagen and elastin production Reduction in wrinkles, fine lines, and sagging Improved skin hydration, firmness, and texture 2
Treatment with heparinase III and hyaluronidase, enzymes degrading glycocalyx components, enhanced neutrophil adhesion
